Fabio Gelsomino

17PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

|Oct 06, 2025
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.

Ming Lei, Michael J Overman, Jin Yao

|Jun 13, 2025
New Frontiers of Biomarkers in Metastatic Colorectal Cancer: Potential and Critical Issues.

Bianca Medici, Stefania Benatti, Massimo Dominici

|Apr 13, 2024
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort.

Francesco Panzuto, Elisa Andrini, Giuseppe Lamberti

|Jan 09, 2024
Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study.

Ingrid Garajová, Annalisa Comandatore, Lenka Boyd

|Nov 25, 2023
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?

Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati

Pageof 3

Frequent Collaborators

6 joint publications

Ingrid Garajovà

4 joint publications

Andrea Spallanzani

3 joint publications

Annarita Pecchi

3 joint publications

Federico Piacentini